Insider Cluster (2 insiders) ·Filed Jul 17, 2026

CORT

CORCEPT THERAPEUTICS INC
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $2.6M total
Actionable Insight • Neutral

The insider sales are too small to convey a meaningful signal. Monitor for any upcoming earnings or corporate events that might prompt larger insider activity, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
CORT ▲ +27.96% at T+20d
NEUTRAL call ✓ call won +27.96% · α vs SPY +23.84% · entry $91.57 → $117.17
Next anchor: T+60d in 10d
Latest observation: T+51 -28.13% FF3 residual α
Entry anchored
Jul 17, 03:59 PM ET
via exchange tick
T+1d
+4.46%
call +4.46% · α +3.62%
$95.65
settled 2mo ago
T+5d
+4.14%
call +4.14% · α +4.56%
$95.36
settled 2mo ago
T+20d
+27.96%
call +27.96% · α +23.84%
$117.17
settled 7w ago
T+60d
—
call — · α —
—
in 10d

Price Chart

Loading chart...

Executive Summary

Two Corcept Therapeutics insiders (CFO Mokari Atabak and Director James N. Wilson) sold a combined $2.59M in open-market shares on July 15, 2026. The total represents just 0.027% of the $9.6B market cap, making the sales trivial and routine in nature.

Key Financial Metrics

Direction
selling
Total Value
$2.6M
Insiders
2

Key Facts

  • CFO Mokari Atabak sold 39,999 shares for ~$3.51M total, including derivative exercises and open-market sales; open-market portion was ~$2.50M
  • Director James N. Wilson sold 10,000 shares for ~$883K in open-market transactions
  • Total open-market sales of $2.59M represent ~0.027% of CORT's $9.6B market cap
  • No insider purchases were reported in the cluster window

Financial Impact

Insider sales of $2.59M are immaterial relative to $9.6B market cap; no financial impact on the company

Risk Factors

  • Insider selling could accelerate if the stock continues to rise, but current levels are routine
  • No evidence of informed selling; sales likely tied to option exercises and personal liquidity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CORT-1784329294717
26 reports for CORT
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +63.06%Feb 24, 2026
Filters
Rows
Reports for CORT — sortable, filterable
TypeNow
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $115.63▲ +1.54%▲ +1.28%$116.23 (+2.06%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $116.10▲ +1.95%▲ +1.44%$116.23 (+2.06%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$116.93 $117.00▲ +0.06%▲ +0.16%$116.23 (−0.60%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$121.05 $114.86▼ −5.11%▼ −5.11%$116.23 (−3.98%)
Aug 18, 2026
6w ago
Insider Cluster
BEARISH ★ 4/10
$118.10 $111.85▲ +5.29%▲ +4.30%$116.23 (+1.58%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.23 (+3.61%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.23 (+3.61%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$110.77 $111.62▲ +0.77%▲ +1.16%$116.23 (+4.93%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.95 $112.80▲ +4.49%▲ +3.89%$116.23 (+7.67%)
Jul 23, 2026
10w ago
Court Ruling
BULLISH ★ 4/10
$96.66 $121.05▲ +25.23%▲ +21.92%$116.23 (+20.25%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 17, 2026